InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of disease-modifying small molecule drug candidates that target CB1CB2 receptors, today…
Brien Lundin, editor of Gold Newsletter and New Orleans Investment Conference host, shares his stock-picking strategy at a time when high metals prices are beginning to lift all…
Listen up, flyers: United Airlines said it will start removing passengers from flights who refuse to wear headphones while listening to content on their personal devices, and such…